Navigation Links
Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Bioniche Life Sciences Inc.
Date:3/26/2008

NEW YORK, March 26 /PRNewswire/ -- Crystal Research Associates, LLC announced today that it has issued an Executive Informational Overview(R) (EIO(R)) on Bioniche Life Sciences Inc. (TSX: BNC). The full 68-page report can be found at http://www.crystalra.com.

Bioniche is a Canadian biopharmaceutical company that is committed to improving the quality of life in both humans and animals worldwide through innovative research, novel technologies, and therapeutics. Bioniche operates three global business units: (1) Human Health; (2) Food Safety; and (3) Animal Health. The Company's research focuses on developing proprietary platform technologies that are used to create its human and animal therapeutic agents.

The most advanced human product candidate for Bioniche is Urocidin(TM) to treat non muscle-invasive bladder cancer. Urocidin(TM) entered Phase III clinical development in late 2006 after receiving Fast Track status from the U.S. Food and Drug Administration (FDA). A second Phase III trial with Urocidin(TM) is scheduled to begin in 2008 under the FDA's Special Protocol Assessment (SPA) and Fast Track designations.

The Company's Food Safety unit develops veterinary biopharmaceuticals to improve the safety of human food and water supplies. Its most significant initiative is a vaccine that, when administered to cattle, reduces the level of Escherichia coli (E. coli) O157:H7 that can be shed into the environment, thereby seeking to reduce human illnesses from contaminated food and water. The vaccine has been widely tested and should receive a U.S. Department of Agriculture (USDA) conditional license in 2008. It already has a conditional license equivalent in Canada. In September 2007, the first commercial beef producer, Ontario-based Top Meadow Farms, began using Bioniche's cattle vaccine. By January 2008, the Company had received C$20 million in funding for its C$25 million vaccine productio
'/>"/>

SOURCE Crystal Research Associates, LLC
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on CEL-SCI Corporation
2. Velos to Develop Key System Interface for Clinical Research
3. Rexinoid Developed by NuRx Pharmaceuticals Shows Promise in Prevention, Treatment of Lung, Breast Cancer, Paper in Clinical Cancer Research Reports
4. Carpet One Floor & Home Continues Making Dramatic Strides in Funding Breast Cancer Research and Awareness
5. Molecular Science Could Further Improve Leukemia Survival, Say St. Jude Researchers
6. Poniard Pharmaceuticals Announces Clinical Data From Picoplatin Oral Phase 1 to Be Presented at the American Association of Cancer Research Annual Meeting
7. Micromet Announces Presentation of Five Posters Related to Its Proprietary BiTE Antibody Platform at Annual Meeting of American Association for Cancer Research
8. Evanston Northwestern Healthcare Researchers Explain Effects of Large-Scale, Universal MRSA Surveillance Program That Supports Expanded Intervention
9. Women Invited to Join New Health Registry to Advance Research
10. Northern California Foot and Ankle Center Santa Rosa Enrolling Patients With Chronic Diabetic Foot Ulcers for Matrix Clinical Research Trial
11. Mayo Clinic Proceedings Contributors Highlight Research Findings About Cardiovascular Benefits Associated With Omega-3 Fatty Acids

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... , NEW YORK, Dec. 2 R...ch report is available in its catalogue: ,, P...et Trends ,, http://www.reportlinker.com/p0...bal-Market-Trends.html ,, Global pharma indu...easing competition in generic markets, rising cost...
(Date:12/2/2009)... , ABBOTT PARK, Ill., Dec. 2 /PRNewswire-Fir...and characterizing a vast array of microorganisms ...by The Scientist magazine. A panel of expert ju...ologies to determine the year,s top innovations, w...mber issue and online at www.the-scien t ist.c...
(Date:12/2/2009)... , LEXINGTON, Mass. and HEIDELBERG, Ge...s been recognized as one of the winners of the "To...ine. The company,s automated sequence capture tech... due to its exceptional combinations of invention,...ed a panel of expert judges to evaluate a broad ra...
Breaking Medicine Technology:Reportlinker Adds Pharmaceutical Contract Manufacturing - Global Market Trends 2Reportlinker Adds Pharmaceutical Contract Manufacturing - Global Market Trends 3Reportlinker Adds Pharmaceutical Contract Manufacturing - Global Market Trends 4Reportlinker Adds Pharmaceutical Contract Manufacturing - Global Market Trends 5Abbott's Ibis Technology Named One of the Top Innovations for 2009 by The Scientist 2The Scientist Magazine Recognizes febit's HybSelect(TM) Among the Winners of 'Top 10 Innovations of 2009' 2Putting Nanotechnology on the Map 54733 1Putting Nanotechnology on the Map 54733 2Putting Nanotechnology on the Map 54733 3Abnormal Protein May Signal Pancreatic Cancer 54730 1Abnormal Protein May Signal Pancreatic Cancer 54730 2Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 1Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 2Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 3Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 4Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 5Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 6Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 7Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 8Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 9Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 10Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 11Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 12Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 13Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 14Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 15Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 16Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 17Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 18Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 19Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 20Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 21Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 22Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 23Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 24Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 25Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 26Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 27Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 28Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 29Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 30Perrigo Reports Record Sales Earnings and Cash Flow From Operations for Fiscal 2009 54728 31
...l Inc., a cardiac device company with novel techno...successfully advanced its device to first-in-human...ld company. , , The first patient was successful...India. The patient had a significant improvement i... preliminary data from a 20-patient pilot study. P...
...lar efficacy to Avastin alone and in combination w... side-effects; study validates results seen in Pre...CESS PHARMACEUTICALS, INC. (OTC Bulletin Board: AC...y humanized monoclonal antibody, Angiolix, which c... to the its target, lactadherin, resulting in anti...
Other Medicine Technology:Mardil Inc. Advances Its Novel Cardiac Device to First-In-Human Trials for Mitral Valve Regurgitation 2Access Pharmaceuticals Presents new Combination Data on the Company's Angiolix(R) Therapeutic Monoclonal Antibody 2Access Pharmaceuticals Presents new Combination Data on the Company's Angiolix(R) Therapeutic Monoclonal Antibody 3
(Date:12/2/2009)..., , NEW YORK, Dec. 2 ...rch report is available in its catalogue: ,, ..., http://www.reportlinker.com/p0166820/Sterilizat... the North American sales of capital equipment to ...the market,s compound annual growth rate for 2009-...
(Date:12/2/2009)..., , NEW YORK, Dec. 2 ...arch report is available in its catalogue: ,, ...//www.reportlinker.com/p0166819/Kinase-Inhibitors-...bal market, providing data for the years 2005 thro...und annual growth rates (CAGRs) through 2014 ,...
(Date:12/2/2009)..., , WASHINGTON, Dec. 2 /PRNewswire-USNews...eld today on " Supplement Safety Now ," an ini...nd other organizations, the Council for Responsibl...epresenting the dietary supplement industry, issue...Steve Mister , President and CEO: ,, "We sha...
(Date:12/2/2009)..., , SEOUL, South Korea, Dec. 2 /PRNews...ty Chest of Seoul, Korea Telecom (KT), MacroEye an...its Wireless Reach(TM) initiative, today announced...evices, services and applications through the "Seo...mobile handsets and devices to caregivers and seni...
(Date:12/2/2009)..., , BOSTON, Dec. 2 /PRNewswire/ -...ebsite traffic rises 8%. According to Coremetrics... rose 13.7 percent on Cyber Monday compared to Cyb... Boston,s Bella Sante Day Spas who reported toda... Monday Internet sales rose 59%" - said Tiffany Am...
Breaking Medicine News(10 mins):Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 2Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 3Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 4Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 5Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 6Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 7Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 8Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 9Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 10Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 11Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 12Health News:Reportlinker Adds Sterilization Technologies: The U.S. Market 13Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 2Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 3Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 4Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 5Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 6Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 7Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 8Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 9Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 10Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 11Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 12Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 13Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 14Health News:Reportlinker Adds Kinase Inhibitors: Global Markets 15Health News:CRN Responds to 'Supplement Safety Now' Initiative 2Health News:CRN Responds to 'Supplement Safety Now' Initiative 3Health News:Qualcomm, City of Seoul, Korea Telecom and MacroEye Leverage the Power of 3G to Connect Low Income and Disabled Senior Citizens to Caregivers 2Health News:Qualcomm, City of Seoul, Korea Telecom and MacroEye Leverage the Power of 3G to Connect Low Income and Disabled Senior Citizens to Caregivers 3Health News:Qualcomm, City of Seoul, Korea Telecom and MacroEye Leverage the Power of 3G to Connect Low Income and Disabled Senior Citizens to Caregivers 4Health News:The Washington Post Reported That Cyber Monday Website Traffic Rises 8%. Boston's Bella Sante Day Spas Cyber Monday Website Traffic Rises 76%. 2Health News:The Washington Post Reported That Cyber Monday Website Traffic Rises 8%. Boston's Bella Sante Day Spas Cyber Monday Website Traffic Rises 76%. 3
...orlds leading causes of blindness in an oven clean... used to polish glass and remove grease could be u...University of Central Florida scientists report in...nhibits carbonic anhydrase II enzyme, but also ten...
...oreign medical schools, including those from India...ore starting next year, the health ministry said S...untries like the Philippines, India and Myanmar, h...is to ease the shortage of physicians. The...
...ate the deadly poliomyelitis virus within two year...Conference (OIC) member states, Afghan Health Min... About 7.4 million children in Afghanistan needed...e might cause harm, said Muhammed Amin on the KL-O...
...c kidney disease are independently associated with...heart disease is associated with a decline in kidn... according to two reports in the issue of Archives...formation in the articles. Chronic kidney disease ...
...lready but they plan to add to their family in a b...on Stewart inquired as to just how many kids Angel... replied that she wanted to have as many as 14 lit...I'll tell you this: I admire that, because two is ...
...she became HIV infected. Six years later, she is f... and teaching them how to live with the disease . ...last three years, 27-year-old Hina from Davangere ... organised a four day National Conclave of Margina...
Other Medicine News:Health News:Studies Identify Interactions Between Heart Disease, Kidney Disease 2Health News:AIDS Patient Helps Others Lead a Positive Life 2
MEDPOR Barrier Miniplate Channel Implant
MEDPOR Midface Rim
Akahoshi Prechop (12 o'clock approach)
Nagahara Blade
Medicine Products: